Form D · Biotechnology
149 Medical, Inc.
Worcester, MA · CIK 0001787145
Offering snapshot reported Apr 13, 2021 · SEC filing
- Reported sold
- $250K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 26, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2021 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Sep 5, 2019 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-395486
Source: Form D, filed Apr 13, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Abe | Director |
| Antoniu Fantana | Director, Executive |
| William Shaw | Director, Executive |
| Bernhard Zimmermann | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17 Briden Street
Worcester, MA, 01605
Worcester, MA, 01605